Common use of Approval of Marketing Materials Clause in Contracts

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – — Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement.Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: e. Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five (5) business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the reviewer AFD notifies Insurance Company of any required changes within five (5) business days of his/her receipt of the material. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 11 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: MEMBERS Life Insurance Company Attn: Office of General Counsel 0000 Xxxxxxx Xxxxx Xxxx Xxxxxxx, XX 00000 Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five (5) business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communicationscommunications related to the Funds. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the AFD reviewer notifies Insurance Company of any required changes within five business days of his/her receipt of the material. No review of such material produced by Insurance Company shall be necessary if all references contained in such materials regarding the Funds or CRMC are identical to those references that appear in the Series' current prospectus(es) or statement(s) of additional information. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFDAFD or the Series' current prospectus(es) or statement(s) of additional information, unless specifically approved in writing by AFD. Neither Except as set forth above, neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s 's web site shall include the full name of the Fund and a reference to “"American Funds Insurance Series.” " By way of example, “"American Funds Insurance Series – Series- Growth Fund”". If field size prohibits the use of the full name of the Fund and a reference to “"American Funds Insurance Series”", the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s 's and/or the Distributor’s 's name (the “"Insurance Company Material”") prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s 's Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing). Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s 's current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – — Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five (5) business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the reviewer AFD notifies Insurance Company of any required changes within five (5) business days of his/her receipt of the material. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – — Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five (5) business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Except as provided below, the Insurance Company will not give any information or make any representations or statements on behalf of the Series or concerning the Series in connection with the sale of the Contracts other than the information or representations contained in the registration statement, prospectus or SAI for Series shares, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in reports or proxy statements for the Series, or in published reports for the Series which are in the public domain or approved by the Series or AFD or their designees for distribution, or in sales literature or other material provided by the Series or by AFD, except with permission of the Series or AFD or their designees. The Series and AFD agree to respond to any request for approval on a prompt and timely basis. b. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communicationscommunications that refer to Funds. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials material and any other disclosure for which it seeks approval to AFD ten (10) business days prior to their first use for its review and AFD shall have five (5) business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by AFD or otherwise by or on behalf of the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the reviewer at AFD notifies Insurance Company of any required changes within five (5) business days of his/her receipt of the material. b. c. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. d. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. e. The Funds, CRMC, or AFD will not give any information or make any representations or statements on behalf of the Insurance Company shall have or concerning the right to approve all sales material that mentions Insurance Company’s and/or , a Separate Account, or the Distributor’s name Contracts other than the information or representations contained in a registration statement, prospectus or SAI for the Contracts, as such registration statement, prospectus and SAI may be amended or supplemented from time to time, or in published reports for each Separate Account or the Contracts which are in the public domain or approved by the Insurance Company for distribution to Contract owners, or in sales literature or other material provided by the Insurance Company, except with written permission of the Insurance Company. The Insurance Company agrees to respond to any request for approval on a prompt and timely basis. f. The Funds, CRMC, or AFD will furnish, or will cause to be furnished, to the Insurance Company or its designee, each piece of sales literature or other promotional material in which the Insurance Company or its Accounts, or its affiliates are named and any other disclosure for which they seek approval (the “Insurance Company Material”Material”)at least ten (10) business days prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: Xxx Xxxxxxxx 000 Xxxxxx Xxxxxx X Xxxxxxxxxxx, XX 00000 xxx.xxxxxxxx@xxxxxxxx.xxx Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five (5) business days of his/her receipt of Insurance Company Material. No review of sales material or other promotional material produced by AFD AFD, CRMC, and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company Company, its Accounts, and/or the Distributor its affiliates are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company The Society may, based on the SEC-mandated information supplied by AFD, prepare communicationscommunications in which the Accounts, Certificates, the Funds, and/or CRMC are named. In addition, Insurance Company the Society may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company The Society shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five ten business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company The Society shall be responsible for all other errors or omissions. Any such material will be deemed approved unless AFD, the reviewer, notifies the Society of any required changes within ten business days of his/her receipt of the material. The Society will coordinate with the Distributor with respect to the Society’s review of communications and any filing requirements with FINRA. b. Neither Insurance Company the Society nor any person associated with Insurance Company the Society shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the registration statement for the Funds as may be amended or supplemented from time to time and in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company the Society nor any person associated with Insurance Company the Society shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder Certificate Holder statements and on Insurance Companythe Society’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – - Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company The Funds, AFD or its designee shall have furnish, or shall cause to be furnished to the right to approve all Society or its designee, each piece of sales material that mentions Insurance Company’s in which the Society, the Accounts and/or the Distributor’s name (the “Insurance Company Material”) Certificates are named at least ten business days prior to its use. AFD No such material shall be used if the Society or its designee reasonably objects to such use within ten business days after receipt of such material. Notwithstanding that the Society or its designee did not initially object, the Society or its designee reserves the right to reasonably object to the continued use of any such sales material in which the Society, the Accounts and/or CRMC the Certificates are named and no such material shall send all Insurance be used if the Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreementor its designee so object. e. Insurance Company Material The Funds will be deemed approved unless provide to the reviewer for Insurance Company notifies AFD and/or CRMC Society at least one complete copy of all final prospectuses, Statements of Additional Information, proxy statements, and all amendments to any required changes within five of the above, that relate to the Funds or their shares, as soon as reasonably practicable after the filing of such document with the Securities and Exchange Commission (“SEC”) or other regulatory authorities. The Fund shall furnish to the Society at least ten business days prior to its first submission to the SEC or its staff, any request or filing for no-action assurance or exemptive relief naming the Society, the Accounts, or the Certificates. f. Neither the Funds, AFD, CRMC nor any person associated with the Funds, AFD or CRMC shall make any representations on behalf of his/her receipt of Insurance Company Material. No review of or concerning the Society, each Account, or the Certificates other than information or representations contained in the registration statement for the Certificates, as such registration statement may be amended or supplemented from time to time, or in published reports for each Account which are in the public domain or approved by the Society for distribution to Certificate Holders, or in sales material produced approved by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or Society or its designee, except with the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) permission of additional informationthe Society.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and approval. All such material will be deemed approved unless the reviewer for AFD shall have five notifies Insurance Company of any required changes within fifteen business days to approve or reject such materialof AFD's receipt of Insurance Company materials. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s 's web site shall include the full name of the Fund and a reference to “"American Funds Insurance Series.” " By way of example, “"American Funds Insurance Series – - Growth Fund”". If field size prohibits the use of the full name of the Fund and a reference Fund, references to “"American Funds Insurance Series”, the Fund name " may be abbreviated as "AFIS" and references to a Fund may be abbreviated as, for example, "AFIS - Growth Fund". Other methods of abbreviation may be allowed with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s 's and/or the Distributor’s 's name (the “"Insurance Company Material”") prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s 's Director of Marketing Literature at the address listed in Section 12 of this Agreement.Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: Manager, Investment Operations A7-4478 Securian Financial Group 000 Xxxxxx Xx N St Xxxx, MN 55101-2098 e. Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s 's current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the reviewer AFD notifies Insurance Company of any required changes within five business days of his/her receipt of the material. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s 's web site shall include the full name of the Fund and a reference to “"American Funds Insurance Series.” " By way of example, “"American Funds Insurance Series – Series- Growth Fund”". If field size prohibits the use of the full name of the Fund and a reference to “"American Funds Insurance Series”", the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s 's and/or the Distributor’s 's name (the “"Insurance Company Material”") prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s 's Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s 's current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five (5) business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the reviewer AFD notifies Insurance Company of any required changes within five (5) business days of his/her receipt of the material. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s 's web site shall include the full name of the Fund and a reference to “"American Funds Insurance Series.” " By way of example, “"American Funds Insurance Series – Growth Fund”". If field size prohibits the use of the full name of the Fund and a reference to “"American Funds Insurance Series”", the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s 's and/or the Distributor’s 's name (the “"Insurance Company Material”") prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s 's Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five (5) business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s 's current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communications. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFD, unless specifically approved in writing by AFD. Neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s web site shall include the full name of the Fund and a reference to “American Funds Insurance Series.” By way of example, “American Funds Insurance Series – Growth Fund”. If field size prohibits the use of the full name of the Fund and a reference to “American Funds Insurance Series”, the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s and/or the Distributor’s name (the “Insurance Company Material”) prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s Director of Marketing Literature at the address listed in Section 12 of this Agreement.Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing) at the following address: e. Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s current Contract prospectus(es) or statement(s) of additional information.

Approval of Marketing Materials. a. Insurance Company may, based on the SEC-mandated information supplied by AFD, prepare communicationscommunications related to the Funds. In addition, Insurance Company may prepare such materials, based on performance information supplied by third party information providers (e.g., Lipper, Morningstar). Insurance Company shall provide copies of all such materials to AFD prior to their first use for its review and AFD shall have five business days to approve or reject such material. It is understood that AFD shall be responsible for errors or omissions in, or the content of, such materials based upon information supplied by the Funds. Insurance Company shall be responsible for all other errors or omissions. Any such material will be deemed approved unless the AFD reviewer notifies Insurance Company of any required changes within five business days of his/her receipt of the material. No review of such material produced by Insurance Company shall be necessary if all references contained in such materials regarding the Funds or CRMC are identical to those references that appear in the Series' current prospectus( es) or statement(s) of additional information. b. Neither Insurance Company nor any person associated with Insurance Company shall make representations concerning a Fund, CRMC or its affiliates, except those contained in the current promotional literature produced by AFDAFD or the Series' current prospectus(es) or statement(s) of additional information, unless specifically approved in writing by AFD. Neither Except as set forth above, neither Insurance Company nor any person associated with Insurance Company shall make use of the names, logos or any likeness of the Funds, CRMC or its affiliates without the prior written consent of AFD. c. References to the Funds on Contractholder statements and on Insurance Company’s 's web site shall include the full name of the Fund and a reference to “"American Funds Insurance Series.” " By way of example, “"American Funds Insurance Series – Growth -Growth Fund”". If field size prohibits the use of the full name of the Fund and a reference to “"American Funds Insurance Series”", the Fund name may be abbreviated with the approval of AFD. d. Insurance Company shall have the right to approve all sales material that mentions Insurance Company’s 's and/or the Distributor’s 's name (the “"Insurance Company Material”") prior to its use. AFD and/or CRMC shall send all Insurance Company Material to Insurance Company’s 's Director of Marketing Literature at the address listed in Section 12 of this Agreement. e. Agreement (or such other person as Insurance Company may direct AFD and/or CRMC in writing). Insurance Company Material will be deemed approved unless the reviewer for Insurance Company notifies AFD and/or CRMC of any required changes within five business days of his/her receipt of Insurance Company Material. No review of sales material produced by AFD and/or the Series shall be necessary if all references contained in such materials regarding Insurance Company and/or the Distributor are identical to those references that appear in Insurance Company’s 's current Contract prospectus(es) or statement(s) of additional information.